LNP-miR-155 cy5 Inhibitor Regulates the Copper Transporter via the β-Catenin/TCF4/SLC31A1 Signal for Colorectal Cancer Therapy-Reference-Cited by-同舟云学术

LNP-miR-155 cy5 Inhibitor Regulates the Copper Transporter via the β-Catenin/TCF4/SLC31A1 Signal for Colorectal Cancer Therapy

Published:2023-06-26 Issue:8 Volume:20 Page:4138-4152
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Jiang Fan¹,Du Le²,Chen Zhi-ju³,Wang Xiang³,Ge Dongsheng³,Liu Ning³^ORCID

Affiliation:

1. Department of the Center of Gerontology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570311, P. R. China

2. Department of Biology, Hainan Medical University, Haikou, Hainan 570100, P. R. China

3. Department of Gastrointestinal Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570311, P. R. China

Funder

Hainan Province Science and Technology Special Fund

Hainan Provincial Natural Science Foundation of china

National Natural Science Fund Cultivating Fund 530 Project of Hainan General Hospital

Hainan Provincial Health Industry Scientific Research Project

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00276

Reference36 articles.